You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract

  • Technology appraisal guidance
  • Reference number: TA272
  • Published:  23 January 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Transitional cell carcinoma of the urothelial tract - vinflunine: consultee and commentator comments on the ACD

  • Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre

  • Transitional cell carcinoma of the urothelial tract - vinflunine: Action on Bladder Cancer

  • Transitional cell carcinoma of the urothelial tract - vinflunine: British Uro-oncology Group

  • Transitional cell carcinoma of the urothelial tract - vinflunine: joint response from NCRI/Royal College of Physicians/RCR/ACP/JCCO

  • Transitional cell carcinoma of the urothelial tract - vinflunine: NHS Norfolk


This page was last updated: 07 March 2011

Back to top